Venetoclax with Azacitidine or Low Dose Cytarabine As an Alternative to Intensive Chemotherapy in Fit Adults during the COVID19 Pandemic: Real World Data from the UK National Health Service
Resource Type
Article
Authors
Othman, Jad ; Amer, Mariam ; Amofa, Ruebina ; Anderson, Laura ; Austin, Michael J ; Bashford, Alex ; Belsham, Edward ; Boot, Jesca ; Campbell, Victoria Louise ; Coats, Thomas ; Collins, Angela ; Crawley, Charles ; Crolla, Francesca ; Cross, Joe W ; Dalley, Chris ; Dang, Raymond ; Dennis, Mike ; Dhawan, Saniya ; Elliott, Johnathon ; Galli, Sofia ; Gallipoli, Paolo ; Hodgson, Katherine ; Jain, Manish ; Kalkur, Pallavi ; Katsomitrou, Vana ; Khan, Anjum ; Khwaja, Asim ; Krishnamurthy, Pramila ; Latif, Annie ; Laurie, John ; Lim, Michael ; Loizou, Eleana ; Loke, Justin ; Mannari, Deepak ; Manson, Cara ; Marshall, Scott R. ; Mobashwera, Behnaz ; Murthy, Vidhya ; Ochaya, Odong ; Orthi, Shahzad ; Palanicawandar, Renuka ; Pillai, Srinivas ; Radzova, Dominika ; Rye, Adam ; Saunders, Jamie ; Smith, Matthew ; Taussig, David ; Taylor, Tom ; Whitmill, Richard ; Zhao, Rui ; Freeman, Sylvie D ; Craddock, Charles ; Dillon, Richard
Source
Blood; November 2021, Vol. 138 Issue: 1, Number 1 Supplement 1 p2321-2321, 1p
Subject
Language
ISSN
00064971; 15280020